Cardio Diagnostics Holdings Inc Financials
Cardio Diagnostics Holdings Inc (CDIO) reported $14K in revenue over the twelve months to Jun 30, 2026, down 25.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cardio Diagnostics’ dominant mechanic is financing dependence: operating losses persist despite low leverage and a sharp FY2025 revenue contraction
The business did not convert scale into operating leverage: revenue rose104.4% from FY2023 to FY2024, but operating loss widened15.5% ; the subsequent FY2025 contraction coincided with a narrower loss, pointing to cost movement rather than scalable revenue economics.
In FY2025, liabilities represented
FY2025 free cash flow was
Financial Health Signals
Cardio Diagnostics Holdings Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Cardio Diagnostics Holdings Inc scores -3.06, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($5.5M) relative to total liabilities ($793K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cardio Diagnostics Holdings Inc passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Cardio Diagnostics Holdings Inc reported a net loss of $6.5M while operations used $5.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Cardio Diagnostics Holdings Inc reported an operating loss of $6.5M against $15K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Cardio Diagnostics Holdings Inc generated $15K in revenue in fiscal year 2025. This represents a decrease of 57.5% from the prior year.
Cardio Diagnostics Holdings Inc's EBITDA was -$6.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 23.1% from the prior year.
Cardio Diagnostics Holdings Inc reported -$6.5M in net income in fiscal year 2025. This represents an increase of 22.5% from the prior year.
Cardio Diagnostics Holdings Inc earned -$3.71 per diluted share (EPS) in fiscal year 2025.
Cash & Balance Sheet
Cardio Diagnostics Holdings Inc recorded an outflow of $5.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 13.6% from the prior year.
Cardio Diagnostics Holdings Inc held $0 in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Cardio Diagnostics Holdings Inc's ROE was -93.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.5 percentage points from the prior year.
Not reported for fiscal year 2025.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Cardio Diagnostics Holdings Inc invested $641K in research and development in fiscal year 2025. This represents an increase of 181.3% from the prior year.
Cardio Diagnostics Holdings Inc invested $187K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 12.8% from the prior year.
Not reported for fiscal year 2025.
CDIO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5K+100.0% | $3K-24.6% | $4K+24.5% | $3K-61.8% | $7K+695.2% | $940-79.2% | $5K-31.4% | $7K |
| R&D Expenses | $163K+25.5% | $130K-16.2% | $155K-18.1% | $189K+5.9% | $179K+50.3% | $119K-41.9% | $205K+3799.4% | $5K |
| SG&A Expenses | $1.1M-21.3% | $1.5M+319.9% | $347K-79.8% | $1.7M+1.7% | $1.7M+31.9% | $1.3M+1300.5% | $91K-93.6% | $1.4M |
| Operating Income | -$1.5M+16.1% | -$1.8M-22.0% | -$1.5M+14.5% | -$1.7M-2.0% | -$1.7M-3.0% | -$1.6M-7.5% | -$1.5M-7.6% | -$1.4M |
| Interest Expense | $3K0.0% | $3K+50.0% | $2K-26.7% | $3K-33.3% | $5K0.0% | $5K+50.0% | $3K-19.4% | $4K |
| Net Income | -$1.5M+16.0% | -$1.8M-22.0% | -$1.5M+14.5% | -$1.7M-1.9% | -$1.7M-2.9% | -$1.6M-7.6% | -$1.5M-7.6% | -$1.4M |
| EPS (Diluted) | -$0.51+19.0% | -$0.63 | -$0.80+18.4% | -$0.98-1.0% | -$0.970.0% | -$0.97 | -$0.28 | -$1.73 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Income Tax.
CDIO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.9M-17.1% | $9.6M+23.1% | $7.8M-11.6% | $8.8M-15.5% | $10.4M-15.4% | $12.3M+15.7% | $10.6M+136.9% | $4.5M |
| Current Assets | $6.2M-20.5% | $7.7M+30.8% | $5.9M-14.5% | $6.9M-20.4% | $8.7M-17.4% | $10.5M+19.8% | $8.8M+234.6% | $2.6M |
| Cash & Equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $4K-8.6% | $4K-47.4% | $8K-27.6% | $11K-13.2% | $13K+35.3% | $10K-48.7% | $19K+32.0% | $14K |
| Total Liabilities | $500K-23.8% | $656K-17.3% | $793K+24.4% | $637K-5.1% | $672K-25.8% | $905K-14.4% | $1.1M+33.0% | $795K |
| Current Liabilities | $359K-26.9% | $491K-18.7% | $605K+51.8% | $398K+7.8% | $370K-31.6% | $541K-14.4% | $632K+104.6% | $309K |
| Total Equity | $7.4M-16.6% | $8.9M+27.7% | $7.0M-14.5% | $8.2M-16.2% | $9.7M-14.5% | $11.4M+19.0% | $9.6M+159.3% | $3.7M |
| Retained Earnings | -$32.5M-4.8% | -$31.0M-6.1% | -$29.3M-5.3% | -$27.8M-6.6% | -$26.1M-6.9% | -$24.4M-7.2% | -$22.8M-7.2% | -$21.2M |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
CDIO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.3M+14.1% | -$1.6M-14.7% | -$1.4M+2.3% | -$1.4M+11.3% | -$1.6M-12.2% | -$1.4M-0.6% | -$1.4M-20.3% | -$1.2M |
| Capital Expenditures | $0-100.0% | $2K | $0-100.0% | $163K+771.0% | $19K+223.1% | $6K+59.1% | $4K-84.3% | $23K |
| Free Cash Flow | -$1.3M+14.2% | -$1.6M-14.8% | -$1.4M+12.5% | -$1.6M+2.1% | -$1.6M-13.1% | -$1.4M-0.7% | -$1.4M-18.2% | -$1.2M |
| Investing Cash Flow | -$47K+26.5% | -$64K+18.7% | -$78K+69.6% | -$258K-621.8% | -$36K+24.7% | -$47K+13.2% | -$55K+30.5% | -$79K |
| Financing Cash Flow | -$101K-102.8% | $3.6M+1736.4% | $196K+389.6% | $40K+134.7% | -$115K-103.5% | $3.3M-54.6% | $7.3M+282.1% | $1.9M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CDIO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -27950.5% | -66598.4% | -41159.6% | -59950.9% | -22457.5% | -173463.8% | -33608.2% | -21412.9% |
| Net Margin | -28012.5% | -66722.3% | -41219.9% | -60053.8% | -22517.7% | -173943.0% | -33672.6% | -21467.6% |
| Return on Equity | -20.2%-0.1pp | -20.1%+0.9pp | -21.0%0.0pp | -21.0%-3.7pp | -17.3%-2.9pp | -14.4%+1.5pp | -15.9%+22.4pp | -38.3% |
| Return on Assets | -18.9%-0.2pp | -18.7%+0.2pp | -18.9%+0.6pp | -19.5%-3.3pp | -16.2%-2.9pp | -13.3%+1.0pp | -14.3%+17.2pp | -31.5% |
| Current Ratio | 17.15+1.4x | 15.76+6.0x | 9.79-7.6x | 17.39-6.2x | 23.55+4.1x | 19.49+5.6x | 13.92+5.4x | 8.51 |
| Debt-to-Equity | 0.070.0x | 0.070.0x | 0.110.0x | 0.080.0x | 0.070.0x | 0.080.0x | 0.11-0.1x | 0.22 |
| FCF Margin | -25044.1% | -58357.2% | -38308.0% | -54509.7% | -21273.1% | -149562.6% | -30938.2% | -17942.3% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Cardio Diagnostics Holdings Inc Ranks
Frequently Asked Questions
What is Cardio Diagnostics Holdings Inc's annual revenue?
Cardio Diagnostics Holdings Inc (CDIO) reported $15K in total revenue for fiscal year 2025. This represents a -57.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cardio Diagnostics Holdings Inc's revenue growing?
Cardio Diagnostics Holdings Inc (CDIO) revenue declined by 57.5% year-over-year, from $35K to $15K in fiscal year 2025.
Is Cardio Diagnostics Holdings Inc profitable?
No, Cardio Diagnostics Holdings Inc (CDIO) reported a net income of -$6.5M in fiscal year 2025.
What is Cardio Diagnostics Holdings Inc's EBITDA?
Cardio Diagnostics Holdings Inc (CDIO) had EBITDA of -$6.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Cardio Diagnostics Holdings Inc's return on equity (ROE)?
Cardio Diagnostics Holdings Inc (CDIO) has a return on equity of -93.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Cardio Diagnostics Holdings Inc's free cash flow?
Cardio Diagnostics Holdings Inc (CDIO) recorded an outflow of $5.9M in free cash flow during fiscal year 2025. This represents a -13.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cardio Diagnostics Holdings Inc's operating cash flow?
Cardio Diagnostics Holdings Inc (CDIO) recorded an outflow of $5.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Cardio Diagnostics Holdings Inc's total assets?
Cardio Diagnostics Holdings Inc (CDIO) had $7.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Cardio Diagnostics Holdings Inc's capital expenditures?
Cardio Diagnostics Holdings Inc (CDIO) invested $187K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Cardio Diagnostics Holdings Inc spend on research and development?
Cardio Diagnostics Holdings Inc (CDIO) invested $641K in research and development during fiscal year 2025.
What is Cardio Diagnostics Holdings Inc's current ratio?
Cardio Diagnostics Holdings Inc (CDIO) had a current ratio of 9.79 as of fiscal year 2025, which is generally considered healthy.
What is Cardio Diagnostics Holdings Inc's debt-to-equity ratio?
Cardio Diagnostics Holdings Inc (CDIO) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cardio Diagnostics Holdings Inc's return on assets (ROA)?
Cardio Diagnostics Holdings Inc (CDIO) had a return on assets of -83.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Cardio Diagnostics Holdings Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Cardio Diagnostics Holdings Inc (CDIO) held $0 in cash, cash equivalents and investments, and reported an operating cash outflow of $5.7M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Cardio Diagnostics Holdings Inc's Altman Z-Score?
Cardio Diagnostics Holdings Inc (CDIO) has an Altman Z-Score of -3.06, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cardio Diagnostics Holdings Inc's Piotroski F-Score?
Cardio Diagnostics Holdings Inc (CDIO) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cardio Diagnostics Holdings Inc's earnings high quality?
Cardio Diagnostics Holdings Inc (CDIO) reported a net loss of $6.5M while operations used $5.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Cardio Diagnostics Holdings Inc cover its interest payments?
Cardio Diagnostics Holdings Inc (CDIO) reported an operating loss of $6.5M against $15K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.